Samokhvalov Victor, Zlobine Igor, Jamieson Kristi L, Jurasz Paul, Chen Christopher, Lee Kin Sing Stephen, Hammock Bruce D, Seubert John M
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada; Department of Pharmacology, Faculty of Medicine, University of Alberta, Edmonton, AB, Canada.
Toxicol Lett. 2015 Jan 5;232(1):10-20. doi: 10.1016/j.toxlet.2014.09.029. Epub 2014 Oct 6.
Docosahexaenoic acid (22:6n3, DHA) is an n-3 polyunsaturated fatty acid (PUFA) known to affect numerous biological functions. While DHA possesses many properties that impact cell survival such as suppressing cell growth and inducing apoptosis, the exact molecular and cellular mechanism(s) remain unknown. Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors that regulate many cell pathways including cell death. As DHA acts as a ligand to PPARs the aim of this study was to examine the involvement of PPARδ in DHA-mediated cytotoxicity toward H9c2 cells. Treatment with DHA (100μM) resulted in a significant decline in cell viability, cellular metabolic activity and total antioxidant capacity coinciding with increased total proteasome activities and activity of released lactate dehydrogenase (LDH). No changes in reactive oxygen species (ROS) production or accumulation of lipid peroxidation products were observed but DHA promoted apoptotic cell death as detected by flow cytometry, increased caspase-3 activity and decreased phosphorylation of Akt. Importantly, DHA enhanced PPARδ DNA binding activity in H9c2 cells strongly signifying that the cytotoxic effect of DHA might be mediated via PPARδ signaling. Co-treatment with the selective PPARδ antagonist GSK 3787 (1μM) abolished the cytotoxic effects of DHA in H9c2 cells. Cytotoxic effects of DHA were attenuated by co-treatment with myriocin, a selective inhibitor of serine palmitoyl transferase (SPT), preventing de novo ceramide biosynthesis. LC/MS analysis revealed that treatment with DHA resulted in the accumulation of ceramide, which was blocked by GSK 3787. Interestingly, inhibition of cytochrome P450 (CYP) oxidase with MS-PPOH (50μM) abolished DHA-mediated cytotoxicity suggesting downstream metabolites as the active mediators. We further demonstrate that CYP oxidase metabolites of DHA, methyl epoxy docosapentaenoate (EDP methyl esters, 1μM) (mix 1:1:1:1:1:1; 4,5-, 7,8-, 10,11-, 13,14-, 16,17- and 19,20-EDP methyl esters) and 19,20-EDP cause cytotoxicity via activation of PPARδ signaling leading to increased levels of intracellular ceramide. These results illustrate novel pathways for DHA-induced cytotoxicity that suggest an important role for CYP-derived metabolites, EDPs.
二十二碳六烯酸(22:6n3,DHA)是一种n-3多不饱和脂肪酸(PUFA),已知其会影响多种生物学功能。虽然DHA具有许多影响细胞存活的特性,如抑制细胞生长和诱导细胞凋亡,但其确切的分子和细胞机制仍不清楚。过氧化物酶体增殖物激活受体(PPARs)是一类核受体,可调节包括细胞死亡在内的许多细胞信号通路。由于DHA可作为PPARs的配体,本研究旨在探讨PPARδ在DHA介导的对H9c2细胞的细胞毒性中的作用。用DHA(100μM)处理导致细胞活力、细胞代谢活性和总抗氧化能力显著下降,同时总蛋白酶体活性和释放的乳酸脱氢酶(LDH)活性增加。未观察到活性氧(ROS)产生或脂质过氧化产物积累的变化,但通过流式细胞术检测发现DHA促进了凋亡细胞死亡,增加了caspase-3活性并降低了Akt的磷酸化水平。重要的是,DHA增强了H9c2细胞中PPARδ的DNA结合活性,强烈表明DHA的细胞毒性作用可能是通过PPARδ信号传导介导的。与选择性PPARδ拮抗剂GSK 3787(1μM)共同处理可消除DHA对H9c2细胞的细胞毒性作用。与丝氨酸棕榈酰转移酶(SPT)的选择性抑制剂麦角硫因共同处理可减弱DHA的细胞毒性作用,麦角硫因可阻止神经酰胺的从头生物合成。液相色谱/质谱分析表明,用DHA处理会导致神经酰胺积累,而GSK 3787可阻断这种积累。有趣的是,用MS-PPOH(50μM)抑制细胞色素P450(CYP)氧化酶可消除DHA介导的细胞毒性,表明下游代谢产物是活性介质。我们进一步证明,DHA的CYP氧化酶代谢产物,甲基环氧二十二碳五烯酸酯(EDP甲酯,1μM)(混合比例为1:1:1:1:1:1;4,5-、7,8-、10,11-、13,14-、16,17-和19,20-EDP甲酯)和19,20-EDP通过激活PPARδ信号传导导致细胞毒性,从而导致细胞内神经酰胺水平升高。这些结果阐明了DHA诱导细胞毒性的新途径,表明CYP衍生的代谢产物EDP具有重要作用。